Surface Engineered Iron Oxide Nanoparticles Generated by Inert Gas Condensation for Biomedical Applications

Aver Hemben,Iva Chianella,Glenn John Thomas Leighton
DOI: https://doi.org/10.3390/bioengineering8030038
IF: 5.046
2021-03-15
Bioengineering
Abstract:Despite the lifesaving medical discoveries of the last century, there is still an urgent need to improve the curative rate and reduce mortality in many fatal diseases such as cancer. One of the main requirements is to find new ways to deliver therapeutics/drugs more efficiently and only to affected tissues/organs. An exciting new technology is nanomaterials which are being widely investigated as potential nanocarriers to achieve localized drug delivery that would improve therapy and reduce adverse drug side effects. Among all the nanocarriers, iron oxide nanoparticles (IONPs) are one of the most promising as, thanks to their paramagnetic/superparamagnetic properties, they can be easily modified with chemical and biological functions and can be visualized inside the body by magnetic resonance imaging (MRI), while delivering the targeted therapy. Therefore, iron oxide nanoparticles were produced here with a novel method and their properties for potential applications in both diagnostics and therapeutics were investigated. The novel method involves production of free standing IONPs by inert gas condensation via the Mantis NanoGen Trio physical vapor deposition system. The IONPs were first sputtered and deposited on plasma cleaned, polyethylene glycol (PEG) coated silicon wafers. Surface modification of the cleaned wafer with PEG enabled deposition of free-standing IONPs, as once produced, the soft-landed IONPs were suspended by dissolution of the PEG layer in water. Transmission electron microscopic (TEM) characterization revealed free standing, iron oxide nanoparticles with size < 20 nm within a polymer matrix. The nanoparticles were analyzed also by Atomic Force Microscope (AFM), Dynamic Light Scattering (DLS) and NanoSight Nanoparticle Tacking Analysis (NTA). Therefore, our work confirms that inert gas condensation by the Mantis NanoGen Trio physical vapor deposition sputtering at room temperature can be successfully used as a scalable, reproducible process to prepare free-standing IONPs. The PEG- IONPs produced in this work do not require further purification and thanks to their tunable narrow size distribution have potential to be a powerful tool for biomedical applications.
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to improve the stability and biocompatibility of iron oxide nanoparticles (IONPs) in biomedical applications, especially in order to achieve more effective drug delivery and diagnostic techniques. Specifically, researchers produced free - standing iron oxide nanoparticles with polyethylene glycol (PEG) surface modification by the inert gas condensation method (IGC) combined with magnetron sputtering technology. The IONPs produced by this method have a narrow size distribution and do not require further purification, showing great potential as efficient carriers in drug delivery systems. In addition, the biocompatibility of these PEG - IONPs and their applications in drug delivery are being further studied. The key points of the paper include: - **Production method**: Use the Mantis NanoGen Trio system to produce IONPs through IGC and magnetron sputtering technology. - **Surface modification**: Use PEG coating to increase the stability and biocompatibility of IONPs. - **Size control**: By adjusting parameters such as argon gas flow rate and power, effective control of the size and size distribution of IONPs has been achieved. - **Characterization techniques**: A variety of techniques such as transmission electron microscopy (TEM), atomic force microscopy (AFM), dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA) were used to characterize IONPs in detail. In short, this research aims to develop a new, scalable and reproducible method to produce iron oxide nanoparticles with high stability and biocompatibility to meet the needs of the biomedical field for efficient drug delivery and diagnostic techniques.